CAS No. |
26020-14-4 |
|---|---|
中文名称 |
(2S,3S,4S,5R,6R)-6-[[(3S,4aR,6aR,6bS,8aS,12aS,14aR,14bR)-8a-羧基-4,4,6a,6b,11,11,14b-七甲基-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-二十氢并四苯-3-基]氧基]-3,4,5-三羟基四氢-2H-吡喃-2-羧酸 |
英文名称 |
(2S,3S,4S,5R,6R)-6-(((3S,4AR,6aR,6bS,8aS,12aS,14aR,14bR)-8a-carboxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid |
别名 |
Q27104421 | CS-0100275 | Silphioside F | .BETA.-D-GLUCOPYRANOSIDURONIC ACID, (3.BETA.)-17-CARBOXY-28-NOROLEAN-12-EN-3-YL | GLUCOPYRANOSIDURONIC ACID, 3.BETA.-HYDROXYOLEAN-12-EN-28-OIC ACID, .BETA.-D- | AC-34369 | Calenduloside E | OLEANOLIC ACID 3-O-.BETA |
标准英文名 |
Calenduloside E |
MDL No. |
- |
分子式 |
C36H56O9 |
分子量 |
632.84 |
精确分子量 |
632.39 |
SMILES |
O=C([C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@H]2CC[C@]3(C)[C@@]4([H])CC=C5[C@]6([H])CC(C)(C)CC[C@]6(C(O)=O)CC[C@@]5(C)[C@]4(C)CC[C@@]3([H])C2(C)C)O1)O |
标准SMILES |
CC1(C)C[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@@H]([C@@H](O)[C@H](O)[C@H]6O)C(O)=O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@]2(CC1)C(O)=O |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
IUCHKMAZAWJNBJ-RCYXVVTDSA-N |
危险类别(旧) |
H302,H315,H319 |
存储要求 |
Inert atmosphere, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|